Dr. Goff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2001 - 2004
The University of Texas Health Science Center at San AntonioClass of 2001
Certifications & Licensure
TN State Medical License 2004 - 2025
AL State Medical License 2020 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors Start of enrollment: 2007 Aug 01
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Start of enrollment: 2016 Feb 19
- A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Start of enrollment: 2016 May 19
Publications & Presentations
PubMed
- 1890 citationsNCCN clinical practice guidelines in oncology: hepatobiliary cancers.Al B. Benson, Thomas A. Abrams, Edgar Ben-Josef, P. Mark Bloomston, Jean F. Botha
Journal of the National Comprehensive Cancer Network. 2009-04-01 - 14 citationsA Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.Dana Backlund Cardin, Ramya Thota, Laura W. Goff, Jordan Berlin, Clyde M. Jones
American Journal of Clinical Oncology. 2017-03-01 - 90 citationsFatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?Mina F. Nordness, Stephanie Hamel, Caroline M Godfrey, Chanjuan Shi, Douglas B. Johnson
American Journal of Transplantation. 2020-03-01
Lectures
- New Multidisciplinary Approaches to Diagnosis and Palliation in Hepato-Pancreato-Biliary TumorsASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Sequencing Systemic Therapy in Hepatocellular Carcinoma: Immune Checkpoint Inhibitor or Tyrosine...ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
Press Mentions
NALIRIFOX: A New Reference Standard for Metastatic Pancreatic AdenocarcinomaJanuary 23rd, 2023- Renewed Interest in Radiation for Hepatocellular Carcinoma?January 23rd, 2023
- New First-Line Standard for Metastatic Pancreatic CancerJanuary 22nd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
